| Date | Title | Description |
| 26.03.2024 | Teva UK and Closed Loop Medicine announce strategic partners... | Castleford and London, UK, 26th March 2024: Teva UK Limited and Closed Loop Medicine Ltd have announ... |
| 18.03.2024 | RQ Biotechnology Ltd. Celebrates Milestone with Grant of GB ... | RQ Biotechnology Ltd. (“RQ”) a leader in the discovery of antibodies for the treatment of infectious... |
| 15.03.2024 | Cumulus Neuroscience Announces First Patient Enrolled in Acc... | NIHR-Funded Study Represents the Largest of its Kind Conducted to Date in Alzheimer’s Dementia
BELF... |
| 12.03.2024 | Cumulus Neuroscience Presents Data at AD/PD™ 2024 Annual Mee... | Data presented at the 2024 Alzheimer’s & Parkinson’s Diseases (AD/PD) Conference provides valida... |
| 08.02.2024 | Closed Loop Medicine demonstrates application of novel drug ... | London, UK, Thursday 8th February 2024: Closed Loop Medicine Ltd., a leading TechBio company develop... |
| 01.02.2024 | Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO | 1 February 2024 – Cambridge, UK – Maxion Therapeutics (“Maxion”), the biotechnology company developi... |
| 25.01.2024 | Six new investments, portfolio progress and an expanding inv... | Clare Terlouw, Head of LifeArc Ventures, said: “Our portfolio of investments expanded during the yea... |
| 07.11.2023 | AviadoBio Announces FDA IND Clearance and Fast Track Designa... | London, UK; November 6, 2023 — AviadoBio, a pioneering gene therapy company dedicated to developing ... |
| 25.10.2023 | Cumulus Neuroscience Presents Data at CTAD 2023 Annual Meeti... | Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing ne... |
| 10.10.2023 | AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ... | London, UK; October 10, 2023 — AviadoBio, a pioneering gene therapy company developing and deliverin... |
| 22.09.2023 | Ion Channel Drug Developer Maxion Therapeutics Appoints Eva-... | Cambridge, UK – 21 September 2023 – Today, Maxion Therapeutics (“Maxion”), the biotechnology company... |
| 04.08.2023 | Ozlo Sleep Emerges from Stealth and Unveils Flagship Product... | BOSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) — Ozlo Sleep (Ozlo), a science-driven sleep and audio technol... |
| 18.07.2023 | Cumulus Neuroscience Presents Data at AAIC 2023 Annual Meeti... | BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 17, 2023 /PRNewswire/ — Cumulus Neuroscience (C... |
| 13.07.2023 | Cumulus Neuroscience Announces Research Collaboration with t... | BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 13, 2023 /PRNewswire/ — Cumulus Neuroscience (C... |
| 12.07.2023 | Cumulus Neuroscience Presents Key Data at the 2023 ENCALS An... | BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 12, 2023 /PRNewswire/ — Cumulus Neuroscience (C... |
| 12.07.2023 | LifeArc Ventures Invests in Affect Therapeutics $16 million ... | McLean, VA, July 12, 2023 – Affect Therapeutics (“Affect”), a company reimagining addiction treatmen... |
| 11.07.2023 | Cumulus Neuroscience to Present Data at AAIC 2023 Annual Mee... | BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 11, 2023 /PRNewswire/ — Cumulus Neuroscience (C... |
| 07.07.2023 | Cumulus Neuroscience to Present Data at 2023 ENCALS Annual M... | BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 6, 2023 /PRNewswire/ — Cumulus Neuroscience (Cu... |
| 01.06.2023 | Cumulus Neuroscience Receives FDA 510(k) Clearance for Award... | User-friendly electroencephalogram (EEG) synced device enables self-directed use and generates clini... |
| 01.06.2023 | Cumulus Neuroscience LandsCoveted iF Design and Red DotAward... | Used to Help Accelerate the Study and Development of Precision CNS Medicines, the Cumulus EEG Headse... |
| 18.05.2023 | Closed Loop Medicine and Pharmanovia enter a co-development ... | London and Basildon, UK, 17 May 2023: Closed Loop Medicine Ltd, a leading TechBio company, developin... |
| 10.05.2023 | Cumulus Neuroscience Receives FDA 510(k) Clearance for Award... | Cumulus Neuroscience is very proud and excited to announce that our novel, award-winning dry-sensor ... |
| 19.04.2023 | Maxion Therapeutics awarded £2 million Innovate UK funding t... | Cambridge, UK – 19 April 2023 – Biotechnology company Maxion Therapeutics (‘Maxion’) today announced... |
| 12.04.2023 | Cumulus Neuroscience ExpandsDevelopment Support of NovelPrec... | BELFAST, Northern Ireland and CAMBRIDGE, Mass., April 11, 2023 /PRNewswire/ — Cumulus Neuroscience (... |
| 15.02.2023 | LifeArc Ventures invests in Maxion Therapeutics to drive ant... | LONDON, UK, 15 February 2023 — LifeArc Ventures, the investment arm of LifeArc, today announced its ... |
| 10.02.2023 | Cumulus Neuroscience appoints SiggiSaevarsson as COO | He has occupied senior management roles and been on the board of directors forseveral high-growth st... |
| 09.02.2023 | RQ Bio Strengthens Board with Industry-leading Infectious Di... | LONDON, UK, 9 February 2023 — RQ Bio is scaling up at speed, with the appointment of Non- Executive ... |
| 01.02.2023 | Cumulus Neuroscience Expands ExecutiveTeam, Supporting Bioph... | We are delighted to announce the appointment of two biopharma industry experts,expanding our leaders... |
| 01.02.2023 | LifeArc Ventures – strong performance in 2022 & sustaine... | LONDON, UK, 1 February 2023 — LifeArc Ventures, which is committed to investing in innovative early-... |
| 15.11.2022 | LifeArc Ventures invests in Surgery Hero, world’s first digi... | LONDON, UK – LifeArc Ventures, the investment arm of LifeArc, today announced its participation in a... |
| 21.09.2022 | Cumulus Neuroscience appoints digitalhealth and pharmaceutic... | Cumulus Neuroscience has appointed Aman Bhatti, MD, as Chief Executive Officer(CEO). Dr. Bhatti, a n... |
| 08.09.2022 | LifeArc portfolio company Ducentis BioTherapeutics acquired ... | LONDON, UK, 08 September 2022 — LifeArc today announced that its portfolio company Ducentis BioThera... |
| 10.08.2022 | New study highlights superior efficacy of at-home dry EEG as... | Cumulus Neuroscience announces positive results from a new study evaluating thevalidity of using its... |
| 25.05.2022 | Cumulus Neuroscience commences clinicalstudies of digital bi... | Brian Murphy, Cumulus Neuroscience’s Chief Scientific Officer, said: “Currentstandard measurement to... |
| 17.05.2022 | LifeArc co-founded company RQ Bio signs licensing agreement ... | LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it co-founded, has signed a li... |
| 02.12.2021 | LifeArc participates in Series A funding round for company d... | Pioneering gene therapy company AviadoBio’s unique gene therapy platform targeting therapy to the ri... |
| 16.11.2021 | LifeArc unveils new strategy and £1.3 billion spend to drive... | Today, we reinforce our commitment to transform the lives of patients as we announce our new strateg... |
| 04.11.2021 | 10 new data-driven health companies selected for KQ Labs acc... | - |
| 03.11.2021 | LifeArc invests in company developing personalised drug and ... | The deal was led by Ananda Impact Ventures and BGF, and involved a strong syndicate of investors inc... |
| 25.10.2021 | Three new Trustees bring more skills and experience to LifeA... | A very warm welcome to three new Trustees who have joined our Board.
Sue Wallcraft, Ian Nicholson a... |
| 04.05.2021 | LifeArc invests in Cumulus Neuroscience | Life Arc announces it has participated in a £6 million financing round into Cumulus Neuroscience, fo... |
| 22.12.2020 | LifeArc co-leads £6 million funding in DJS Antibodies | LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company p... |
| 23.09.2020 | LifeArc and Future Fund provide £3.0m in funding to Avvinity... | LifeArc, an independent medical research charity, announces a £3.0m co-investment in British biotech... |
| 29.08.2019 | LifeArc Seed Fund makes £1.5million investment in Caldan The... | LifeArc, a UK-based medical research charity, announced today it is investing £1.5million into Calda... |
| 14.06.2019 | LifeArc invests £1.5 million in Ducentis BioTherapeutics | 14 June 2019: LifeArc, a UK-based medical research charity, has made a £1.5 million investment in Du... |
| - | International Women’s Day | We’re lucky to have such remarkable women on board and are grateful for their dedication. Today is a... |
| - | AbbVie acquires LifeArc portfolio company DJS Antibodies | AbbVie (NYSE: ABBV) has acquired LifeArc’s portfolio company DJS Antibodies Limited (“DJS”), a priva... |
| - | AbCellera and RQ Bio Partner | VANCOUVER, British Columbia & LONDON, March 22, 2023 – AbCellera (Nasdaq: ABCL) and RQ Bio annou... |
| - | LifeArc portfolio company RQ Bio’s antibody enters clinical ... | LifeArc Ventures’ portfolio company RQ Biotechnology has announced that the first of its discovered ... |
| - | LifeArc Ventures Investment Principal, Chris Baker, reflects... | The AUTM conference was the first society/association event I’ve attended where diversity and inclus... |
| - | Kovilen Sawmynaden, Senior Principal Scientist at LifeArc, e... | - |
| - | United Nations International Day of Women and Girls in Scien... | With this year’s theme “Bringing Everyone Forward for Sustainable and Equitable Development”, LifeAr... |
| - | Clare Terlouw, Head of LifeArc Ventures, talks about the acq... | - |
| - | Clare Terlouw, Head of LifeArc Ventures, talks about the Lif... | - |
